M Bhargava Selected Research

Takayasu Arteritis (Arteritis, Takayasu's)

12/2000

De novo stenting of descending thoracic aorta in Takayasu arteritis: intermediate-term follow-up results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Bhargava Research Topics

Disease

3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2003 - 07/2000
2	Thalassemia 01/2013 - 10/2007
2	Neoplasms (Cancer) 01/2009 - 07/2005
1	Critical Illness (Critically Ill) 01/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020
1	Tuberculosis (Tuberculoses) 06/2018
1	Hereditary Spherocytosis 06/2018
1	Acute Coronary Syndrome 12/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2015
1	Wounds and Injuries (Trauma) 05/2015
1	Vasculitis (Vasculitides) 03/2014
1	Delta-Beta Thalassemia 01/2013
1	Psoriatic Arthritis 01/2013
1	Retinal Vein Occlusion 02/2012
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 02/2012
1	Microaneurysm 02/2012
1	Hypertensive Retinopathy 02/2012
1	Retinal Hemorrhage 02/2012
1	Retinal Diseases 02/2012
1	Macular Degeneration (Age-Related Maculopathy) 02/2012
1	Macular Edema 02/2012
1	Hypertension (High Blood Pressure) 02/2012
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2011
1	Opportunistic Infections (Opportunistic Infection) 01/2011
1	Osteoarthritis 01/2010
1	Plasma Cell Leukemia 06/2009
1	Squamous Cell Carcinoma of Head and Neck 01/2009
1	beta-Thalassemia (Cooley's Anemia) 10/2007
1	Thrombasthenia (Glanzmann Thrombasthenia) 03/2003
1	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 03/2003
1	Fibrosis (Cirrhosis) 12/2001
1	Hypoxia (Hypoxemia) 12/2001
1	Bacterial Meningitis 11/2001
1	False Aneurysm (Pseudoaneurysm) 12/2000
1	Takayasu Arteritis (Arteritis, Takayasu's) 12/2000
1	Shock 03/2000
1	Hemorrhage 03/2000

Drug/Important Bio-Agent (IBA)

2	Immunoglobulins (Immunoglobulin)IBA 06/2009 - 07/2000
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 06/2018
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 06/2018
1	Coloring Agents (Dyes)IBA 06/2018
1	Cytochrome P-450 CYP2C19IBA 12/2015
1	Cytochrome P-450 CYP3AIBA 12/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2015
1	Clopidogrel (Plavix)FDA Link 12/2015
1	Complement System Proteins (Complement)IBA 03/2014
1	Adalimumab (Humira)FDA Link 01/2013
1	Fetal Hemoglobin (Hemoglobin F)IBA 01/2013
1	Retinaldehyde (Retinal)IBA 02/2012
1	CytokinesIBA 01/2010
1	Oncogene Proteins (Oncogene Protein)IBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 01/2009
1	Staphylococcal Protein A (Protein A)IBA 01/2009
1	hemoglobin D PunjabIBA 10/2007
1	CationsIBA 10/2007
1	DNA (Deoxyribonucleic Acid)IBA 10/2007
1	Cadherins (E-Cadherin)IBA 09/2003
1	Arachidonic Acid (Vitamin F)IBA 03/2003
1	Oxygen (Dioxygen)IBA 12/2001
1	EsterasesIBA 11/2001
1	multidrug resistance-associated protein 1IBA 06/2001
1	Messenger RNA (mRNA)IBA 06/2001
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2000
1	anti-inhibitor coagulant complexIBA 03/2000

Therapy/Procedure

4	Therapeutics 01/2020 - 10/2011
1	Critical Care (Surgical Intensive Care) 01/2020
1	Total Parenteral Nutrition 01/2020
1	Catheters 01/2020
1	Obstetrical Forceps 05/2015
1	Art Therapy 01/2011
1	Aftercare (After-Treatment) 07/2005
1	Stents 12/2000